1. Home
  2. CMA vs RGEN Comparison

CMA vs RGEN Comparison

Compare CMA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comerica Incorporated

CMA

Comerica Incorporated

HOLD

Current Price

$88.63

Market Cap

11.3B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.71

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMA
RGEN
Founded
1849
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CMA
RGEN
Price
$88.63
$166.71
Analyst Decision
Hold
Buy
Analyst Count
21
10
Target Price
$71.45
$174.90
AVG Volume (30 Days)
1.4M
663.3K
Earning Date
01-21-2026
10-28-2025
Dividend Yield
3.21%
N/A
EPS Growth
30.50
N/A
EPS
5.23
0.03
Revenue
$3,234,000,000.00
$707,890,000.00
Revenue This Year
$6.42
$17.84
Revenue Next Year
$3.03
$12.44
P/E Ratio
$16.92
$6,537.77
Revenue Growth
2.31
11.74
52 Week Low
$48.12
$102.97
52 Week High
$90.44
$182.52

Technical Indicators

Market Signals
Indicator
CMA
RGEN
Relative Strength Index (RSI) 71.83 59.62
Support Level $87.54 $156.01
Resistance Level $89.38 $167.74
Average True Range (ATR) 1.64 4.65
MACD 0.06 -0.19
Stochastic Oscillator 77.42 92.75

Price Performance

Historical Comparison
CMA
RGEN

About CMA Comerica Incorporated

With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: